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ABSTRACT
Background: An environmental challenge chamber (ECC), which we refer to as the α-chamber, was built at
Chiba University in 2008. The aim of this study was to validate the functionality of the ECC.
Methods: The stability of the pollen distribution and concentration in the ECC and symptoms of patients with
Japanese cedar pollinosis induced by cedar pollen exposure were examined. Carryover effects of symptoms
induced by different exposure protocols and correlations between symptoms induced in the ECC and those in
the natural cedar pollen season were also determined. All the studies using the α-chamber were conducted out
of the cedar pollen season.
Results: The severity of symptoms in the chamber reached a peak about 2 hours after the start of pollen expo-
sure and plateaued thereafter. After subjects left the chamber, the symptoms persisted for several days. There
was no significant difference between the severity of symptoms at exposure levels of 8000 and 12000 grains
m3. The symptoms were significantly increased by exposure for 3 consecutive days; however, there were no
carryover effects in a study performed with a two-week interval. The total nasal symptom score (TNSS) in the
natural pollen season showed a weak correlation with the mean TNSS on the day of exposure and the following
3 days. Symptoms in the ECC also had weak correlations with those in the early natural pollen season.
Conclusions: The ECC under well-controlled conditions is suitable for clinical studies and might accelerate
development of treatment for seasonal allergic rhinitis. A complete evaluation requires inclusion of the persis-
tent reaction after subjects leave the ECC.
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INTRODUCTION
Clinical trials of treatment for seasonal allergic rhini-
tis (SAR) have to be conducted during the pollen dis-
persal season. However, performance of a reproduc-
ible study is difficult due to annual differences in pol-
len amounts and weather. The amount of pollen expo-
sure also differs by region and due to the lifestyle of
each patient. For these reasons, the environmental
challenge chamber (ECC) was developed to make it
possible to conduct a study under standardized condi-
tions. A well-designed ECC can be used to investigate
the efficacy of treatment for SAR, including drug dose
finding, onset of action, and duration of action.1-6 The
use of ECCs is becoming more common, including a
recent study of the onset of action of sublingual im-
munotherapy.7
Many kinds of pollen cause allergic rhinitis, includ-
ing cedar, cypress, orchard grass, mugwort and rag-
weed.8 In Japan, Japanese cedar (Cryptomeria japon-
ica) pollen is the major allergen and the prevalence of
SAR induced by cedar pollen has increased in the last
10 years, with over 26% of the population now thought
to be affected.9 However, it is difficult to examine the
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exact influence of cedar pollen on nasal symptoms be-
cause other pollens such as cypress and birch are
scattered in a similar period to that of cedar pollen
dispersal.8 Use of an ECC can avoid the confounding
effects of multiple allergens and allow determination
of the effect of each kind of pollen.
An ECC was built in Chiba University in 2008. This
ECC, which we refer to as the α-chamber, can accom-
modate 50 subjects. The α-chamber is the second
largest in capacity worldwide, after the ECC in On-
tario, Canada.10,11 Pollen concentration and distribu-
tion can be examined precisely with 56 automatic pol-
len counters. In this report, we verify the perform-
ance of α-chamber using Japanese cedar pollen expo-
sure and examine the nasal symptoms induced in the
α-chamber.
METHODS
THE ENVIRONMENTAL CHALLENGE CHAMBER
(α-CHAMBER)
The ECC at Chiba University was built in 2008, has
an area and ceiling height of 71.8 m2 and 2.6 m, re-
spectively, and can accommodate up to 50 subjects.
The control room and exposure room are separated
by a glass window that allows medical staff to monitor
subjects during a clinical study. Pollen (Japan Forest
Tree Breeding Association, Tokyo) is supplied from 4
reservoirs outside the exposure room. These reser-
voirs produce pollen and nine fans above the ceiling
agitate the pollen particles. The uniformly agitated
pollen particles drop down from holes in the ceiling.
There are 50 chairs on a mesh floor above the bottom
floor. Pollen that falls through the mesh floor into a
catchment area is circulated back into the chamber to
maintain pollen dispersal throughout the chamber
and to avoid accumulation of pollen on the floor. The
chamber unit is controlled automatically at a constant
temperature and relative humidity.
The pollen level is monitored during exposure at
56 points (including one on the back of each chair)
within the chamber using automatic pollen counters
(Shinyei, Kobe, Japan)12 to check that the concentra-
tion of the pollen remains at a constant level (500-
16,000 grainsm3). Each patient records the frequen-
cies of induced sneezing and rhinorrhea and subjec-
tively assesses symptoms using mobile communica-
tion devices that allow precise evaluation. In the
chamber, patients wear clean disposable clothes, in-
cluding hair caps and shoe covers, to avoid the influ-
ence of suspended dust on subjects and transport of
pollen out of the chamber unit after exposure (Fig.
1).
BASIC PERFORMANCE OF THE α-CHAMBER
The stability of the pollen density in each area of the
ECC and changes in pollen concentration during
movement of the subjects were examined.
VALIDATION STUDIES IN PATIENTS
Subjects
The subjects were patients with SAR caused by Japa-
nese cedar pollen. All subjects had a history of rhini-
tis for at least two consecutive cedar pollen seasons
and met the following inclusion criteria: a positive
allergen-specific skin test (wheal diameter 10 mm)
to standardized cedar pollen extract (Torii Pharma-
ceutical, Tokyo, Japan), and a serum cedar pollen-
specific IgE score 2 in a fluorescent enzyme immu-
noassay (FEIA, SRL, Tokyo, Japan). Exclusion crite-
ria were nasal diseases including AR induced by
other allergens that required treatment, severe
asthma, use of antiallergic drugs within 4 weeks of
the study, pregnant women, women of childbearing
potential, and breastfeeding women.
Study Protocol
The following studies were conducted in the α-
chamber outside the natural cedar pollen season.
a) Changes of nasal symptoms according to the
time course of pollen exposure and the concentration
of pollen particles
Fourteen subjects (12 males and 2 females, aged
27-57 years old) with SAR induced by Japanese cedar
pollen were exposed to cedar pollen at concentrations
of 8,000 and 12,000 grainsm3 for 3 h in the ECC.
Symptoms in the chamber and after leaving the
chamber were evaluated.
b) Carry-over effects
Exposure to 8000 grainsm3 in these subjects was
repeated after an interval of 14 days to examine the
carryover effect. The same subjects were also ex-
posed to 8000 grainsm3 in the ECC for 2 h each day
over the course of 3 consecutive days and changes of
symptoms were evaluated.
c) Comparison of nasal symptoms of patients in the
pollen chamber with those in the natural pollen sea-
son
Correlations between symptoms induced in the
ECC and those in the natural cedar pollen season
were analyzed in another 72 subjects (29 males and
43 females, age 19-66 years old) with cedar pollinosis.
These subjects were exposed to cedar pollen (8000
grainm3) for 3 h in the ECC outside of the cedar pol-
len season. The subjects recorded their symptoms for
4 days, including the day of pollen exposure and the
following 3 days, and also recorded symptoms during
the natural pollen season in 2009 using an allergy di-
ary. These patients were instructed to avoid drug
therapy as much as possible. Pollen counts were de-
termined with a Durham sampler (Nishiseiki,
Funabashi, Japan) using the gravimetric method on
the roof of the Graduate School of Medicine, Chiba
University. All studies were conducted at a university
hospital in compliance with the Ethical Guidelines for
Clinical Studies and Good Clinical Practice and the
Declaration of Helsinki (2008 revision). The protocol
Chiba Environmental Challenge Chamber
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Fig.　1　Equipment used in the α-chamber. (a) Automatic pollen counters on the back of 
each chair. (b) A mobile communication device. (c) Patients wear clean disposable 
clothes, hair caps and shoe covers to avoid transport of pollen out of the chamber after 
exposure.
a b
c
was approved by the Ethics Committee of Chiba Uni-
versity and Chiba University Hospital Clinical Re-
search Center. Each subject received a detailed ex-
planation of the study and of the possible side effects,
and written informed consent was obtained prior to
participation in the study.
Assessment of the Severity of Nasal Symptoms
In the ECC, the subjects recorded the frequencies of
sneezing and nose blowing and subjective assess-
ments of the severity of symptoms (sneezing, rhinor-
rhea and nasal congestion) using a mobile communi-
cation device during cedar pollen exposure, as re-
ported previously.13 The severity of each of the three
symptoms was evaluated on a 4-point scale (0-3): 0,
none; 1, mild; 2, moderate; 3, severe. The total sever-
ity score was defined as the sum of these scores (0-
9). The subjective assessment was conducted every
30 min. We also asked the subjects to record the fre-
quency of symptoms at 3 PM, 6 PM and 9 PM after
leaving the ECC, using an allergy diary.
Modified criteria based on the Practical Guidelines
for the Management of Allergic Rhinitis in Japan (Ta-
ble 1)9 was used for evaluation of nasal symptom
scores over the day on which ECC exposure oc-
curred and for 3 days after leaving the ECC. On each
day, subjects recorded information for sneezing
(number of sneezes per day), rhinorrhea (number of
times blowing the nose per day), and nasal conges-
tion. These data were evaluated on 4-point scales (0-
3) and the total nasal symptom score (TNSS) was de-
fined as the sum of the three scores (0-9).
Statistical Analysis
Data analysis was performed with two-tailed tests at a
significance level of 5%, using a Wilcoxon signed rank
test in SAS v. 8.02 (Cary, NC, USA) for comparison of
nasal symptoms. Pearson correlation coefficients
were used to analyze correlations between symptoms
induced in the ECC and those in the natural cedar
pollen season.
RESULTS
BASIC PERFORMANCE OF THE α-CHAMBER
Cedar pollen concentrations in each of the 9 group ar-
eas of the ECC (Fig. 2) are shown in Figure 3. The
pollen concentration reached 8,000 grainsm3 within
15 min and was maintained at this concentration
thereafter. The difference in concentrations among
areas was small and within ±12%. Movement of sub-
Hamasaki S et al.
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Fig.　2　Design of the α-chamber. There are 9 group areas in the chamber. The pollen concentra-
tion in each area was examined.
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Table　1　Nasal symptom scores over one day
Parameter
Score
3 2 1 0
Sneezing (times/day) 11-20 6-10 1-5 0
Blowing nose (times/day) 11-20 6-10 1-5 0
Nasal congestion Very severe nasal congestion 
with frequent oral breathing
Severe nasal congestion with 
occasional oral breathing
No oral breathing but 
nasal congestion
None
The evaluation of nasal symptom scores was adapted from the Practical Guideline for the Management of Allergic Rhinitis in Japan.8
The most severe symptoms were omitted because such symptoms did not occur in this study.
jects caused the concentration to change, but the tar-
get concentration was quickly restored (Fig. 4).
VALIDATION STUDIES IN PATIENTS
a) Changes of Nasal Symptoms according to the
Time Course of Pollen Exposure and the Con-
centration of Pollen Particles
Changes of severity scores in 14 subjects who under-
went pollen exposure at 8000 grainsm3 for 3 h are
shown in Figure 5. Severity of symptoms in the ECC
reached a peak about 2 h after the beginning of pol-
len exposure and plateaued thereafter. The symp-
toms persisted after the subjects left the ECC, as
shown for sneezing and nose blowing in Figure 6.
The same subjects were exposed to cedar pollen at
12000 grainsm3 for 3 h. There was no significant dif-
ference between the severity of symptoms at 8000
and 12000 grainsm3 (Fig. 7).
b) Carry-Over Effects
Exposure to 8000 grainsm3 in the chamber twice
with a two-week interval did not show any carryover
effects (Fig. 8). However, repeated exposure for 2 h
per day over the course of 3 consecutive days caused
increasingly rapid and marked progression of symp-
toms (Fig. 9). The severity scores for each symptom
on days 2 and 3 were higher than those on day 1 at
some time points.
c) Comparison of Nasal Symptoms of Patients in
the Pollen Chamber with Those in the Natural
Pollen Season
The mean amount of cedar pollen dispersed in the
2009 season was 4372 graincm2day using the Dur-
ham method (Fig. 10). The early natural pollen sea-
son was defined as the period from February 5 to 28
because the peak of pollen dispersal occurred at the
beginning of March. The mean severity scores in the
ECC did not have a significant correlation with the
mean TNSS over the whole natural pollen season, but
did show a moderate correlation (r = 0.48) with the
mean TNSS in the early natural season (Fig. 11a).
The nasal symptoms continued for four days after
exposure in the ECC, although the symptoms amelio-
Chiba Environmental Challenge Chamber
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Fig.　3　Change of cedar pollen concentration in each area of the ECC. The average con-
centration of pollen was 8000 ± 1078 grains in 5 independent experiments. The pollen 
concentration distribution was within a range of ±12% of the target value of 8000 grains/
m3 in the chamber. Data are shown as the mean ± 95%CI.
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Fig.　4　Change of pollen concentration when subjects moved around. Pollen concentra-
tions were measured every 5 min over 3 h while subjects moved around. The pollen count 
at each time point is shown as the average value of all sensors over each 5-min period.
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rated gradually. The score on day 3 is higher than
that of pre-exposure (data not shown). The mean
TNSS over the whole natural season was weakly cor-
related with the mean TNSS for 4 days (day of pollen
exposure and the following 3 days) after exposure in
the ECC (r = 0.33) (Fig. 11b).
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Fig.　5　Change of severity scores in 3-hour pollen exposure of 8000 grains/m3. Subjects record-
ed their symptom scores every 30 min in the chamber (0-180 min) and every 3 h after leaving the 
chamber (3-12 h). Symptoms reached a plateau in about 120 min after the start of exposure. (a) 
Sneezing. (b) Rhinorrhea. (c) Obstruction. (d) TNSS. Data are shown as the mean ± 95%CI.
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Fig.　6　Frequency of sneezing and nose blowing in 3-hour pollen exposure of 8000 
grains/m3. Sneezing and nose blowing still occurred after the subjects left the chamber (3-
12 h). Data are shown as the mean ± 95%CI. *<0.05 vs. before. **<0.01 vs. before.
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Fig.　7　Comparison of severity scores in pollen exposure at 8000 and 12000 
grains/m3. There was no signifi cant difference between exposure at 8000 and 
12000 grains/m3. Data are shown as the mean ± 95%CI.
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Fig.　8　Comparison of severity scores between exposures at a two-week interval. No aggravation of 
symptoms was found in the second study. Data are expressed as the mean ± 95%CI. (a) Sneezing. (b) 
Rhinorrhea. (c) Obstruction. (d) TNSS. Data are shown as the mean ± 95%CI.
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DISCUSSION
ECCs were developed to induce SAR symptoms artifi-
cially under standard conditions. The Vienna Chal-
lenge chamber was the first EEC worldwide and was
first described in 1987.14 An ECC needs to fulfill the
following conditions15: studies are not limited to the
period of natural pollination, controlled and uniform
allergen exposure, no impact of weather conditions,
no impact of personal context, ensured compliance
(medication administration, timeliness and comple-
tion of symptom assessment), and instantaneous and
Hamasaki S et al.
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Fig.　9　Change in severity scores in the EEC in a challenge test for 3 consecutive days. Symptoms were 
increased by 3-day exposure and progression of symptoms became faster and more marked. (a) Sneez-
ing. (b) Rhinorrhea. (c) Obstruction. (d) TNSS. Data are shown as the mean ± 95%CI. *<0.05 vs. day 1 at 
the same time point. **<0.01 vs. day 1 at the same time point.
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precisely timed symptom assessments. Currently,
there are 10 facilities in the world. These chambers
should permit objective evaluation of the severity of
symptoms, but there are some differences in the stan-
dards among the chambers.
We conducted a validation study of the newly built
ECC at Chiba University, which is currently the sec-
ond largest ECC worldwide. Our results showed that
the pollen distribution and concentration were con-
stant based on detailed pollen counts throughout the
chamber using 56 automatic real time pollen count-
ers. Movement of subjects in the chamber only
caused a slight and temporary change in the concen-
tration. Circulation of pollen in the chamber main-
tained a stable distribution and avoided accumulation
of pollen on the floor, which may cause unstable con-
ditions. We also examined the pollen by microscope
on glass slides placed in the chamber and found that
less than 1% of pollens were damaged (data not
shown). These results show that the pollen supply
system in the α-chamber can be used for stable pol-
len exposure.
In the pollen exposure studies in patients with
Japanese cedar pollinosis, significant and reproduc-
ible symptoms were induced in the α-chamber. The
duration of exposure and the concentration for induc-
tion of symptoms were based on the results of valida-
tion studies by Krung et al.16 and Hashiguchi et al.,17
in which exposure for at least 2 h and a concentration
of 8,000 grainsm3 were found to be necessary to ob-
serve symptoms. Exposure to cedar pollen at 8,000
grainsm3 induced symptoms in all of the subjects in
our studies and these symptoms reached a peak after
2 h during exposure in the chamber. The severity
and pattern of symptoms did not differ from those in-
duced by exposure at 12,000 grainsm3. We did not
examine the effects at a lower concentration; how-
ever, exposure at 8,000 grainsm3 has been used
in previous chamber studies with Japanese cedar pol-
len17 and we conclude that this is an appropriate pol-
len concentration.
The slight increase of TNSS at baseline may have
occurred because patients with SAR are frequently
aware of their nasal symptoms when they are not in
the chamber. There was no carryover effect after an
interval of two weeks, which indicates that a cross-
over study with this interval will give comparable
data. In contrast, consecutive daily exposure exagger-
ated the symptoms and carryover effects were clearly
detected. Pollen exposure in the chamber results in
enhanced nasal allergic inflammation and the priming
of allergic inflammation in the nasal mucosa may
Chiba Environmental Challenge Chamber
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Fig.　10　Scattering pattern of Japanese cedar pollen in 2009. Pollen was scattered from 
February 5 to April 19. The total amount of cedar pollen in 2009 was 4372 grain/cm2/day. 
The early natural pollen season was defi ned as the period from February 5 to 28.
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Fig.　11　Correlation between symptoms induced in the ECC and in the natural cedar pollen season. (a) Corre-
lation between the mean severity score in the ECC and the mean TNSS in the early natural pollen season. (b) 
Correlation between the mean TNSS for 4 days (day of pollen exposure and the following 3 days) and the mean 
TNSS over the whole natural pollen season.
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cause severe symptoms.18
Interestingly, persistent symptoms were detected
in all subjects after leaving the chamber. Sneezing,
rhinorrhea and nasal congestion occurred for 3 days
after a single pollen exposure for only 3 h. The sever-
ity of nasal symptoms in the natural pollen season did
Hamasaki S et al.
50 Allergology International Vol 63, No1, 2014 www.jsaweb.jp
not correlate with those in the chamber, but showed
a mild relationship with the mean TNSS for 4 days, in-
cluding the late phase. A previous comparison of re-
sults from an ECC and the natural season showed
that TNSS for 24 h after 4-h ECC exposure correlated
with TNSS during natural exposure.19 Symptoms are
likely to be variable among patients in the natural pol-
len season because of differences in nasal mucosal
sensitivity and in the amount of pollen exposure due
to the region and lifestyle of each patient. However,
there seem to be a correlation between the symptoms
in the ECC on non-pollen season and the symptoms
in the natural pollen season, which indicates the
value of performing studies using the ECC. Thus, our
results show that the α-chamber can be used to per-
form clinical studies and evaluate symptoms in SAR,
including the late phase reaction. The ECC is likely to
accelerate the development of treatment and under-
standing of the detailed mechanisms of allergic in-
flammation.
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